Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 447

1.

Blocking α4β7 integrin binding to SIV does not improve virologic control.

Iwamoto N, Mason RD, Song K, Gorman J, Welles HC, Arthos J, Cicala C, Min S, King HAD, Belli AJ, Reimann KA, Foulds KE, Kwong PD, Lifson JD, Keele BF, Roederer M.

Science. 2019 Sep 6;365(6457):1033-1036. doi: 10.1126/science.aaw7765.

PMID:
31488690
2.
3.

Ultrasound-Proven Severe Synovitis Induced by PD-1 Inhibitor Therapy in a Patient Predisposed to Seronegative Inflammatory Arthritis.

Kawashiri SY, Iwamoto N, Ohba K, Kawakami A.

Case Rep Rheumatol. 2019 Jul 24;2019:7340692. doi: 10.1155/2019/7340692. eCollection 2019.

4.

Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCT.

Iwamoto N, Sato S, Sumiyoshi R, Chiba K, Miyamoto N, Arinaga K, Kobayashi M, Yamamoto H, Osaki M, Kawakami A.

Trials. 2019 Aug 13;20(1):494. doi: 10.1186/s13063-019-3589-8.

5.

Anti-citrullinated protein antibody titre as a predictor of abatacept treatment persistence in patients with rheumatoid arthritis: a prospective cohort study in Japan.

Endo Y, Koga T, Kawashiri SY, Morimoto S, Nishino A, Okamoto M, Eguchi M, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Yoshitama T, Eiraku N, Matsuoka N, Okada A, Fujikawa K, Hamada H, Tsuru T, Nagano S, Arinobu Y, Hidaka T, Tada Y, Kawakami A.

Scand J Rheumatol. 2019 Aug 12:1-5. doi: 10.1080/03009742.2019.1627411. [Epub ahead of print]

PMID:
31402744
6.

Predictive factors of an axillary pathological complete response of node-positive breast cancer to neoadjuvant chemotherapy.

Iwamoto N, Aruga T, Horiguchi S, Saita C, Onishi M, Goto R, Ishiba T, Honda Y, Miyamoto H, Kuroi K.

Surg Today. 2019 Jul 31. doi: 10.1007/s00595-019-01858-x. [Epub ahead of print]

PMID:
31367884
7.

Gastric Perforation due to Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorder during the Treatment of Rheumatoid Arthritis.

Toyama S, Takatani A, Koga T, Eguchi M, Okamoto M, Tsuji S, Endo Y, Shimizu T, Sumiyoshi R, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Furuyama M, Tabuchi M, Kobayashi S, Kanetaka K, Hashisako M, Abe K, Niino D, Sato S, Miyazaki Y, Kawakami A.

Intern Med. 2019 Jul 22. doi: 10.2169/internalmedicine.2782-19. [Epub ahead of print]

8.

Publisher Correction: Claudin-3-deficient C57BL/6J mice display intact brain barriers.

Dias MC, Coisne C, Lazarevic I, Baden P, Hata M, Iwamoto N, Francisco DMF, Vanlandewijck M, He L, Baier FA, Stroka D, Bruggmann R, Lyck R, Enzmann G, Deutsch U, Betsholtz C, Furuse M, Tsukita S, Engelhardt B.

Sci Rep. 2019 Jul 18;9(1):10702. doi: 10.1038/s41598-019-43511-0.

9.

[Toxicity of Palbociclib in Patients Aged 70 Years and Older with Metastatic Breast Cancer].

Iwamoto N, Aruga T, Miyamoto H, Saita C, Onishi M, Goto R, Ishiba T, Honda Y, Kuroi K.

Gan To Kagaku Ryoho. 2019 Jul;46(7):1137-1140. Japanese.

PMID:
31296819
10.

A case of neutrophilic dermatosis with MEFV gene variant and abnormal activation of peripheral blood monocytes: a case report.

Otsuka M, Koga T, Sumiyoshi R, Koike Y, Furukawa K, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Daisuke N, Kawakami A.

Immunol Med. 2019 Mar;42(1):45-49. doi: 10.1080/25785826.2019.1625507. Epub 2019 Jun 16.

PMID:
31204589
11.

Multiplexed monitoring of therapeutic antibodies for inflammatory diseases using Fab-selective proteolysis nSMOL coupled with LC-MS.

Iwamoto N, Takanashi M, Yokoyama K, Yonezawa A, Denda M, Hashimoto M, Tanaka M, Ito H, Matsuura M, Yamamoto S, Honzawa Y, Matsubara K, Shimada T.

J Immunol Methods. 2019 Sep;472:44-54. doi: 10.1016/j.jim.2019.06.014. Epub 2019 Jun 12.

12.

Stereocontrolled Synthesis of Boranophosphate DNA by an Oxazaphospholidine Approach and Evaluation of Its Properties.

Hara RI, Saito T, Kogure T, Hamamura Y, Uchiyama N, Nukaga Y, Iwamoto N, Wada T.

J Org Chem. 2019 Jun 21;84(12):7971-7983. doi: 10.1021/acs.joc.9b00658. Epub 2019 Jun 6.

PMID:
31140804
13.

Rheumatoid arthritis-like active synovitis with T-cell activation in a case of idiopathic multicentric Castleman disease: A case report.

Otsuka M, Koga T, Sumiyoshi R, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Daisuke N, Kawakami A.

Medicine (Baltimore). 2019 May;98(18):e15237. doi: 10.1097/MD.0000000000015237.

14.

Ultrasound-guided fine-needle aspiration of axillary lymph nodes in breast cancer: Diagnostic accuracy and role in surgical management.

Iwamoto N, Aruga T, Horiguchi S, Asami H, Saita C, Onishi M, Goto R, Ishiba T, Honda Y, Miyamoto H, Kuroi K.

Diagn Cytopathol. 2019 Aug;47(8):788-792. doi: 10.1002/dc.24203. Epub 2019 Apr 30.

PMID:
31041851
15.

Clinical features and human T-cell leukemia virus type-1 (HTLV-1) proviral load in HTLV-1-positive patients with rheumatoid arthritis: Baseline data in a single center cohort study.

Eguchi K, Iwanaga M, Terada K, Aramaki T, Tuji Y, Kurushima S, Kojima K, Arima K, Iwamoto N, Ichinose K, Kawakami A, Hirakata N, Ueki Y.

Mod Rheumatol. 2019 Apr 2:1-10. doi: 10.1080/14397595.2019.1602931. [Epub ahead of print]

PMID:
30938551
16.

Knowledge and awareness of nonpharmacist salespersons regarding over-the-counter drug use in patients with chronic kidney disease in Japan.

Kondo Y, Ishitsuka Y, Kawabata N, Iwamoto N, Takahashi R, Narita Y, Kadowaki D, Hirata S, Uchino S, Irie T.

PLoS One. 2019 Mar 20;14(3):e0213763. doi: 10.1371/journal.pone.0213763. eCollection 2019.

17.

Development of Mirror-Image Screening Systems for XIAP BIR3 Domain Inhibitors.

Shu K, Iwamoto N, Honda K, Kondoh Y, Hirano H, Osada H, Ohno H, Fujii N, Oishi S.

Bioconjug Chem. 2019 May 15;30(5):1395-1404. doi: 10.1021/acs.bioconjchem.9b00154. Epub 2019 Apr 17.

PMID:
30888797
18.

Combination of ultrasound power Doppler-verified synovitis and seropositivity accurately identifies patients with early-stage rheumatoid arthritis.

Kawashiri SY, Fujikawa K, Nishino A, Takatani A, Shimizu T, Umeda M, Fukui S, Igawa T, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Mizokami A, Maeda T, Kawakami A.

Int J Rheum Dis. 2019 May;22(5):842-851. doi: 10.1111/1756-185X.13543. Epub 2019 Mar 18.

PMID:
30883001
19.

Treating Pulsatile Exophthalmos in Child with Minimally Invasive Approach and Custom-made Titanium Mesh Plate.

Moriwaki Y, Tomioka Y, Imai H, Iida T, Yamashita S, Kanayama K, Iwamoto N, Okazaki M.

Plast Reconstr Surg Glob Open. 2019 Feb 11;7(2):e2070. doi: 10.1097/GOX.0000000000002070. eCollection 2019 Feb.

20.

Complete renal response at 12 months after induction therapy is associated with renal relapse-free rate in lupus nephritis: a single-center, retrospective cohort study.

Ichinose K, Kitamura M, Sato S, Eguchi M, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Umeda M, Fukui S, Sumiyoshi R, Koga T, Kawashiri S, Iwamoto N, Igawa T, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A.

Lupus. 2019 Apr;28(4):501-509. doi: 10.1177/0961203319829827. Epub 2019 Feb 12.

PMID:
30755146
21.

Novel multiple heterozygous NUDT15 variants cause an azathioprine-induced severe leukopenia in a patient with systemic lupus erythematosus.

Otsuka M, Koga T, Sumiyoshi R, Furukawa K, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Clin Immunol. 2019 Mar;200:64-65. doi: 10.1016/j.clim.2019.02.004. Epub 2019 Feb 8. No abstract available.

PMID:
30742971
22.

Atypical Familial Mediterranean Fever Complicated with Gastrointestinal Amyloidosis Diagnosed due to Paroxysmal Arthralgia and Intractable Diarrhea, Successfully Treated with Tocilizumab.

Aikawa E, Shimizu T, Koga T, Endo Y, Umeda M, Hori T, Irie J, Kuroda K, Eguchi M, Okamoto M, Tsuji S, Takatani A, Igawa T, Sumiyoshi R, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Intern Med. 2019 Jun 15;58(12):1781-1785. doi: 10.2169/internalmedicine.2277-18. Epub 2019 Feb 1.

23.

Incidental Idiopathic Bilateral Pedicle Fracture - Case Report and Literature Review.

Kim K, Isu T, Morimoto D, Kokubo R, Iwamoto N, Morita A.

NMC Case Rep J. 2018 Dec 18;6(1):35-37. doi: 10.2176/nmccrj.cr.2018-0185. eCollection 2019 Jan.

24.

Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort.

Ichinose K, Kitamura M, Sato S, Fujikawa K, Horai Y, Matsuoka N, Tsuboi M, Nonaka F, Shimizu T, Fukui S, Umeda M, Koga T, Kawashiri S, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A.

Lupus. 2019 Mar;28(3):295-303. doi: 10.1177/0961203319826690. Epub 2019 Jan 30.

PMID:
30700214
25.

Serum levels of fibroblast growth factor-2 distinguish Takayasu arteritis from giant cell arteritis independent of age at diagnosis.

Fukui S, Kuwahara-Takaki A, Ono N, Sato S, Koga T, Kawashiri SY, Iwanaga N, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Migita K, Arinobu Y, Niiro H, Tada Y, Akashi K, Maeda T, Kawakami A.

Sci Rep. 2019 Jan 24;9(1):688. doi: 10.1038/s41598-018-36825-y.

26.

Claudin-3-deficient C57BL/6J mice display intact brain barriers.

Castro Dias M, Coisne C, Lazarevic I, Baden P, Hata M, Iwamoto N, Francisco DMF, Vanlandewijck M, He L, Baier FA, Stroka D, Bruggmann R, Lyck R, Enzmann G, Deutsch U, Betsholtz C, Furuse M, Tsukita S, Engelhardt B.

Sci Rep. 2019 Jan 18;9(1):203. doi: 10.1038/s41598-018-36731-3. Erratum in: Sci Rep. 2019 Jul 18;9(1):10702.

27.

Efficacy of infliximab as a switched biologic in rheumatoid arthritis patients in daily clinical practice.

Umeda M, Koga T, Ichinose K, Takatani A, Igawa T, Shimizu T, Fukui S, Nishino A, Horai Y, Hirai Y, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Aramaki T, Ueki Y, Okada A, Fujikawa K, Matsuoka N, Kawakami A.

Immunol Med. 2018 Dec;41(4):181-186. doi: 10.1080/25785826.2018.1542942. Epub 2019 Jan 11.

PMID:
30632931
28.

Utility of power Doppler ultrasonography for detecting forefoot bursae in early rheumatoid arthritis: A case report.

Endo Y, Koga T, Eguchi M, Okamoto M, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Medicine (Baltimore). 2018 Dec;97(51):e13295. doi: 10.1097/MD.0000000000013295.

29.

Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease.

Kawashiri SY, Origuchi T, Umeda M, Nishino A, Shimizu T, Fukui S, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Maeda T, Kawano M, Yamamoto M, Izumi Y, Kawakami A.

Arthritis Res Ther. 2018 Dec 14;20(1):277. doi: 10.1186/s13075-018-1777-7.

30.

Clinical predictors of inadequate response to conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) including methotrexate (MTX) in untreated rheumatoid arthritis patients -A single-center observational study.

Aramaki T, Ueki Y, Kojima K, Kurushima S, Tsuji Y, Kawachi N, Iwamoto N, Ichinose K, Terada K, Eguchi K, Kawakami A.

Mod Rheumatol. 2018 Nov 28:1-18. doi: 10.1080/14397595.2018.1553265. [Epub ahead of print]

PMID:
30482075
31.

Promotion of Calcium/Calmodulin-Dependent Protein Kinase 4 by GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus.

Koga T, Sato T, Furukawa K, Morimoto S, Endo Y, Umeda M, Sumiyoshi R, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Origuchi T, Nakamura H, Kawakami A.

Arthritis Rheumatol. 2019 May;71(5):766-772. doi: 10.1002/art.40785. Epub 2019 Mar 20.

PMID:
30462889
32.

Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: Data from a multicenter, prospective national cohort study in Japan.

Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Agematsu K, Yachie A, Masumoto J, Migita K, Kawakami A.

Arthritis Res Ther. 2018 Nov 20;20(1):257. doi: 10.1186/s13075-018-1738-1.

33.

Paraneoplastic Syndrome Presenting with Polymyalgia Rheumatica-like Accumulations on 18F-fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography.

Umetsu A, Shimizu T, Iwamoto N, Hashiguchi K, Eguchi M, Okamoto M, Endo Y, Tsuji S, Takatani A, Igawa T, Sumiyoshi R, Koga T, Kawashiri SY, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Intern Med. 2019 Mar 15;58(6):861-864. doi: 10.2169/internalmedicine.1847-18. Epub 2018 Nov 19.

34.

Acceleration of nano-surface and molecular-orientation limited (nSMOL) proteolysis with acidified reduction pretreatment for quantification of Tocilizumab.

Iwamoto N, Yonezawa A, Matsubara K, Shimada T.

J Pharm Biomed Anal. 2019 Feb 5;164:467-474. doi: 10.1016/j.jpba.2018.11.019. Epub 2018 Nov 8.

PMID:
30447535
35.

Antineutrophilic cytoplasmic antibody-associated vasculitis with and without renal involvement: C3 contributes to prognosis, but renal involvement does not.

Fukui S, Iwamoto N, Takatani A, Igawa T, Shimizu T, Umeda M, Nishino A, Koga T, Kawashiri SY, Tamai M, Ichinose K, Nakamura H, Origuchi T, Sato S, Kawakami A.

Int J Rheum Dis. 2019 May;22(5):789-796. doi: 10.1111/1756-185X.13422. Epub 2018 Nov 5.

PMID:
30398012
36.

Regulated LC-MS/MS bioanalysis technology for therapeutic antibodies and Fc-fusion proteins using structure-indicated approach.

Iwamoto N, Shimada T.

Drug Metab Pharmacokinet. 2019 Feb;34(1):19-24. doi: 10.1016/j.dmpk.2018.10.002. Epub 2018 Oct 19. Review.

37.

A high throughput lentivirus sieving assay identifies neutralization resistant Envelope sequences and predicts in vivo sieving.

Iwamoto N, Mason R, Hu J, Ransier A, Welles H, Song K, Douek D, Roederer M.

J Immunol Methods. 2019 Jan;464:64-73. doi: 10.1016/j.jim.2018.10.013. Epub 2018 Oct 31.

PMID:
30389575
38.

Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene.

Iida Y, Wakiguchi H, Okazaki F, Nakamura T, Yasudo H, Kubo M, Sugahara K, Yamashita H, Suehiro Y, Okayama N, Hashimoto K, Iwamoto N, Kawakami A, Aoki Y, Takada H, Ohga S, Hasegawa S.

Clin Rheumatol. 2019 Mar;38(3):943-948. doi: 10.1007/s10067-018-4331-8. Epub 2018 Oct 18.

PMID:
30338413
39.

Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritis.

Ichinose K, Kitamura M, Sato S, Fujikawa K, Horai Y, Matsuoka N, Tsuboi M, Nonaka F, Shimizu T, Fukui S, Umeda M, Koga T, Kawashiri SY, Iwamoto N, Igawa T, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A.

Clin Immunol. 2018 Dec;197:161-168. doi: 10.1016/j.clim.2018.10.002. Epub 2018 Oct 5.

PMID:
30296591
40.

Evaluation of circulating invariant T cells before and after IL-17 inhibitor treatment in a patient with psoriatic arthritis.

Koga T, Matoba M, Sato T, Koike Y, Endo Y, Sumiyoshi R, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Clin Immunol. 2018 Dec;197:107-109. doi: 10.1016/j.clim.2018.09.011. Epub 2018 Sep 21. No abstract available.

PMID:
30248399
41.

Subclinical inflammation in a case of menstruation-induced familial Mediterranean fever: A case report.

Hara K, Endo Y, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Migita K, Kawakami A, Koga T.

Medicine (Baltimore). 2018 Sep;97(38):e12305. doi: 10.1097/MD.0000000000012305.

42.

Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs.

Iwamoto N, Okamoto M, Tsuji S, Endo Y, Takatani A, Shimizu T, Umeda M, Fukui S, Sumiyoshi R, Igawa T, Koga T, Kawashiri SY, Aramaki T, Ichinose K, Tamai M, Nakamura H, Origuchi T, Eguchi K, Ueki Y, Kawakami A.

J Bone Miner Metab. 2019 May;37(3):554-562. doi: 10.1007/s00774-018-0955-7. Epub 2018 Sep 5.

PMID:
30187273
43.

Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010.

Ichinose K, Shimizu T, Umeda M, Fukui S, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Sato S, Origuchi T, Kawakami A.

J Immunol Res. 2018 Aug 14;2018:6259010. doi: 10.1155/2018/6259010. eCollection 2018.

44.

Osteogenic differentiation of fibroblast-like synovial cells in rheumatoid arthritis is induced by microRNA-218 through a ROBO/Slit pathway.

Iwamoto N, Fukui S, Takatani A, Shimizu T, Umeda M, Nishino A, Igawa T, Koga T, Kawashiri SY, Ichinose K, Tmai M, Nakamura H, Origuchi T, Chiba K, Osaki M, Jüngel A, Gay S, Kawakami A.

Arthritis Res Ther. 2018 Aug 29;20(1):189. doi: 10.1186/s13075-018-1703-z.

45.

Scleroderma Renal Crisis Complicated with Thrombotic Microangiopathy Triggered by Influenza B Virus Infection.

Shimizu T, Iwamoto N, Okamoto M, Endo Y, Tsuji S, Takatani A, Igawa T, Umeda M, Fukui S, Sumiyoshi R, Kitamura M, Koga T, Kawashiri SY, Ichinose K, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A.

Intern Med. 2019 Feb 1;58(3):441-445. doi: 10.2169/internalmedicine.1441-18. Epub 2018 Aug 24.

46.

Responses to the Letter to the Editor "Does growth-hormone treatment affect patients with and without a mitochondrial disorder differentially ?" (Vol. 27, No. 2, p. 107-108, 2018).

Yokoya S, Hasegawa T, Ozono K, Tanaka H, Kanzaki S, Tanaka T, Chihara K, Jia N, Child CJ, Ihara K, Funai J, Iwamoto N, Seino Y.

Clin Pediatr Endocrinol. 2018;27(3):201-202. doi: 10.1297/cpe.27.201. Epub 2018 Jul 31. No abstract available.

47.

Application of nSMOL coupled with LC-MS bioanalysis for monitoring the Fc-fusion biopharmaceuticals Etanercept and Abatacept in human serum.

Iwamoto N, Yokoyama K, Takanashi M, Yonezawa A, Matsubara K, Shimada T.

Pharmacol Res Perspect. 2018 Jul 24;6(4):e00422. doi: 10.1002/prp2.422. eCollection 2018 Jul.

48.

Undiagnosed Peripheral Nerve Disease in Patients with Failed Lumbar Disc Surgery.

Yamauchi T, Kim K, Isu T, Iwamoto N, Yamazaki K, Matsumoto J, Isobe M.

Asian Spine J. 2018 Aug;12(4):720-725. doi: 10.31616/asj.2018.12.4.720. Epub 2018 Jul 27.

49.

Deep Decompression of the Lateral Femoral Cutaneous Nerve Under Local Anesthesia.

Morimoto D, Kim K, Kokubo R, Kitamura T, Iwamoto N, Matsumoto J, Sugawara A, Isu T, Morita A.

World Neurosurg. 2018 Oct;118:e659-e665. doi: 10.1016/j.wneu.2018.06.252. Epub 2018 Jul 11.

PMID:
30017766
50.

Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis.

Fujita Y, Fukui S, Suzuki T, Ishida M, Endo Y, Tsuji S, Takatani A, Igawa T, Shimizu T, Umeda M, Sumiyoshi R, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Abe K, Kawakami A.

Intern Med. 2018 Dec 1;57(23):3473-3478. doi: 10.2169/internalmedicine.1121-18. Epub 2018 Jul 6.

Supplemental Content

Loading ...
Support Center